CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy.
about
Immune Infiltration and Prostate CancerColony stimulating factor 1 receptor inhibition eliminates microglia and attenuates brain injury after intracerebral hemorrhage.Combinatorial and Computational Approaches to Identify Interactions of Macrophage Colony-stimulating Factor (M-CSF) and Its Receptor c-FMS.Tumor necrosis factor-related apoptosis-inducing ligand induces the expression of proinflammatory cytokines in macrophages and re-educates tumor-associated macrophages to an antitumor phenotypeImmune response to cancer therapy: mounting an effective antitumor response and mechanisms of resistanceTranscriptional profiling of interleukin-2-primed human adipose derived mesenchymal stem cells revealed dramatic changes in stem cells response imposed by replicative senescence.Macrophage Blockade Using CSF1R Inhibitors Reverses the Vascular Leakage Underlying Malignant Ascites in Late-Stage Epithelial Ovarian CancerImmune Modulation by Androgen Deprivation and Radiation Therapy: Implications for Prostate Cancer Immunotherapy.Regulation of prostate cancer progression by the tumor microenvironment.The Promise of Targeting Macrophages in Cancer Therapy.Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma.Tumour-associated macrophages as treatment targets in oncology.Inflammation in Prostatic Hyperplasia and Carcinoma-Basic Scientific Approach.Overcoming Oncogenic Mediated Tumor Immunity in Prostate Cancer.Iron deposition is associated with differential macrophage infiltration and therapeutic response to iron chelation in prostate cancer.High Expression of Colony-Stimulating Factor 1 Receptor Associates with Unfavorable Cancer-Specific Survival of Patients with Clear Cell Renal Cell Carcinoma.Mathematical and Computational Modeling in Complex Biological Systems.A standardized herbal extract mitigates tumor inflammation and augments chemotherapy effect of docetaxel in prostate cancer.Prognostic role of tumour-associated macrophages and macrophage scavenger receptor 1 in prostate cancer: a systematic review and meta-analysis.CSF-1R Inhibitor Development: Current Clinical Status.Inflammatory Cytokine Signaling during Development of Pancreatic and Prostate Cancers.Absence of myeloid Klf4 reduces prostate cancer growth with pro-atherosclerotic activation of tumor myeloid cells and infiltration of CD8 T cells.Contribution of Adipose Tissue to Development of Cancer.The roles of CSFs on the functional polarization of tumor-associated macrophages.The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors.Exosomal αvβ6 integrin is required for monocyte M2 polarization in prostate cancer.Beyond the M-CSF receptor - novel therapeutic targets in tumor-associated macrophages.Multifaceted Roles for Macrophages in Prostate Cancer Skeletal Metastasis.CSF1R-dependent myeloid cells are required for NK‑mediated control of metastasis.Genetics and biology of prostate cancerInhibition of TAMs improves the response to docetaxel in castration-resistant prostate cancerCXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling
P2860
Q26798412-8C0DB434-34F7-4615-8BA5-60470D9935F4Q33828692-F3FD0F7C-6E21-447D-B6D6-F4B5672C7318Q35770311-44C15B30-4210-49E9-8014-FD7AB87467A6Q36058434-5077A3F4-FF80-458A-8F3F-AD2D990957A4Q36125878-9C413BB2-93C5-4AC6-A125-7D1A3C766ED3Q36228470-09337D0C-CD67-45CB-9465-6388B1C5040EQ36362871-A081A39D-4C03-427A-A6A1-E336DA37DF21Q37676065-8B9B113E-0F61-4357-AAE2-59F3CD77DBEEQ38717262-F6D9CB1A-7869-410B-90E1-22000FE5230DQ38877313-C05E82EB-0941-401B-ACC5-2CF3921FBAC5Q39003387-7B976497-E32D-4770-9B45-DAC21CF981D0Q39100693-E74001BF-83C9-4B2F-8E0C-2F1C288EB7B8Q39294665-A10D9F62-EE40-4CC1-8B1A-A8994ED4A50EQ39438805-4C9E823F-F53A-45EA-AB65-F35C835F81A6Q41050245-B16B5E8F-EFC0-4457-807D-5ED905E56938Q41221347-C885765E-0775-4518-9C39-417E8C29986EQ43153782-2DDA2B92-D2BE-404B-AA31-557C199FEE38Q47126582-34AB9089-7C85-4F05-8DAE-082ABD544079Q47165172-74D6EE75-BCEF-4FEB-92BE-737A9E164129Q47963731-335355D5-8640-4164-BC31-8145BBF6A5B3Q48146142-980E7C54-B091-41D5-8EAB-A1B751F77A13Q48259319-A197B2F4-3300-4F6A-8809-121106232D5AQ49164235-ADD93D1D-3DC1-4555-9227-B72344741F4BQ49684254-3189BAA0-D2B0-42A3-B009-1EC4091A36E2Q51822856-77F89933-8C18-4ADE-B17E-05FE47ACE801Q52659954-AACB952E-C061-44A9-9327-F671BAB95FE8Q53099163-FA119E2B-A07E-42B7-A994-4B86FBA80441Q55364968-3A051F28-765A-4329-8487-9E54A8E9C086Q55381087-7C817D75-321F-43F6-98E3-5335177F6A67Q57106917-1E937A23-D369-46F6-9BE2-84DF9085DC27Q58542923-747B9F6A-1B25-49F1-9046-4C37248983C8Q58695499-455EF6C5-1B5E-4C3E-B0EE-1330DE2978B5
P2860
CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
CSF1 receptor targeting in pro ...... to androgen blockade therapy.
@ast
CSF1 receptor targeting in pro ...... to androgen blockade therapy.
@en
type
label
CSF1 receptor targeting in pro ...... to androgen blockade therapy.
@ast
CSF1 receptor targeting in pro ...... to androgen blockade therapy.
@en
prefLabel
CSF1 receptor targeting in pro ...... to androgen blockade therapy.
@ast
CSF1 receptor targeting in pro ...... to androgen blockade therapy.
@en
P2093
P2860
P1433
P1476
CSF1 receptor targeting in pro ...... to androgen blockade therapy.
@en
P2093
Clara Magyar
Connie Liu
Frederic Pouliot
Gideon Bollag
James L Sung
Jemima Escamilla
Jiaoti Huang
Jingying Xu
P2860
P304
P356
10.1158/0008-5472.CAN-14-0992
P407
P577
2015-03-03T00:00:00Z